“…Likewise, dyslipidemia has been detected in patients diagnosed with IBD [35–37]. Similar to the findings in humans, altered lipid profiles have been recognized in dogs diagnosed with idiopathic hyperlipidemia [38,39], diabetes mellitus [40], parvoviral infection [41], cancer [42], renal disease [43,44], or systemic infections [45]. Besides possibly contributing to the pathogenesis of those diseases, several studies have demonstrated lipids, in particular polyunsaturated fatty acids (PUFA), to also have immunomodulatory, anti-inflammatory, and potentially other beneficial effects both in human [46–48] and in veterinary patients [49,50].…”